Pretend you are the lab ops lead and force the lab package to survive questions about who can freeze a specimen chain rewrite, how reagent stockouts are timed across benches, and which assays still lack a named owner when the live sample disagrees with the slide.
This seat sits between lab tools and the turnaround health claims leadership will quote. It asks which specimen trees invent completeness the page export never measured, which turnaround ladders look crisp on a slide and soft in the live sample, and what happens when a lab exception lands because ownership is incomplete. A green lab board does not answer those questions. The review needs the specimen map, turnaround calendar, exception packet, and the named person who can freeze a lab path.
Build the brief the seat can attack
Hand over the lab tools in use, specimen scorecard draft, turnaround cut plan, reagent stockout packet, last clinician-visible result gaps, and one recent case where a delayed specimen rewrite hurt a lab narrative. Include which assay promises still bypass the same review. State the decision: clear the lab change, revise specific controls, or hold until a specimen owner is named.
Boundaries matter. The lab ops lead can challenge untested specimen trees, turnaround windows that ignore measured lead time, exceptions without a kill switch, and override paths without logging. Clinical outcome ownership stays with ordering clinicians. Spend ceilings belong in the same packet so a quiet dashboard does not hide a brittle lab path.
Force concrete answers
- Which critical specimen class still lacks a tested chain path with a measured age-out, and who owns the gap?
- What must hold before a specimen chain rewrite can promote into a lasting rule, and who can waive it without a written reason?
- How does a declined lab exception become visible to the requester within the claimed window?
- What is the measured time from a failed reagent finding to a human with freeze authority?
- Which shared override can ship many lab changes without failing a single turnaround health check?
- Who has authority to pause exceptions or force a lab rollback at week end without waiting for the system owner?
Require observed, inferred, or unknown labels. Observed claims need a source. Unknowns become owners and due dates. When two teams claim the same lab authority, force one named decision before the next tool change starts.
Turn objections into freeze conditions
Run the role in Pingpong with the same exhibits the lab team will use. Have the home team answer each objection in writing. The useful output is a short lab ledger: approved specimen classes, blocked classes, turnaround windows, and the person who can call a freeze.
For adjacent lab work, pair this seat with a specimen chain rewrite, a reagent stockout stress test, a turnaround SLA cut, and the quality ops lead seat. The war-game decisions hub has more seats. Before approving the package, make the lab ops lead write the exact freeze and specimen check that will decide whether the change continues.